Skip to content
★ Sign in to follow
TC

Thomas C. Reynolds

Lite Strategy, Inc.Seagen Inc.
Total declarations
116
Companies
2
▲ Purchases (1 ops.)
€14k
▼ Sales (58 ops.)
€12.0M

Latest filing published 20 Dec 2019 for Lite Strategy, Inc., €14k.

Filing timeline

BuySale
Thomas C. Reynolds

Insider track record

Disclosed buys
1
Disclosed sells
58
Signal history

No signal scores available.

Closed purchases

Market purchases
1

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Since each purchase

  • Filed 20 Dec 2019 · 2515 days ago · €14k
    +46.0%
    Entry US$40.00 · Close at T+365 US$58.40

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Thomas C. Reynolds: trading record in brief

Filings by Thomas C. Reynolds span 2 companies, the busiest being Seagen Inc. and Lite Strategy, Inc. Between 22 September 2008 and 19 December 2019, the trades on record add up to 116 filings.

Market trades split into 1 purchase (€14k) and 58 sales (€12.0M). On balance, insiders were net sellers of €12.0M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 3 share grants and 54 option exercises. So far in 2019, the count stands at 1 purchase and no sales.

The record was last updated on 20 December 2019 with an open-market purchase (€14k) in Lite Strategy, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Thomas C. Reynolds

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations103 total
  • ▲
    DirectorExecutivesLite Strategy, Inc.
    16,000 USD37SEC
    10,000 shares@ US$1.60100.0% of flowCommon StockSEC:0001209191-19-061475:0
    Canonical exit: 18 Mar 2020 (T+90)
  • ◇
    Chief Medical OfficerExecutivesSeagen Inc.
    32,203 USD0SEC
    2,083 shares@ US$15.46Common StockSEC:0001203311-13-000008:0
  • ▼
    Chief Medical OfficerExecutivesSeagen Inc.
    62,157 USD0SEC
    2,083 shares@ US$29.84Common StockSEC:0001203311-13-000008:1
  • ◇
    Chief Medical OfficerExecutivesSeagen Inc.
    12,488 USD0SEC
    1,027 shares@ US$12.16Common StockSEC:0001203311-13-000008:2
  • ▼
    Chief Medical OfficerExecutivesSeagen Inc.
    31,005 USD0SEC
    1,027 shares@ US$30.19Common StockSEC:0001203311-13-000008:3
  • ◇
    Chief Medical OfficerExecutivesSeagen Inc.
    19,164 USD0SEC
    1,576 shares@ US$12.16Common StockSEC:0001203311-13-000008:4
  • ▼
    Chief Medical OfficerExecutivesSeagen Inc.
    47,579 USD0SEC
    1,576 shares@ US$30.19Common StockSEC:0001203311-13-000008:5
  • ◇
    Chief Medical OfficerExecutivesSeagen Inc.
    31,248 USD0SEC
    2,604 shares@ US$12.00Common StockSEC:0001203311-13-000008:6
  • ▼
    Chief Medical OfficerExecutivesSeagen Inc.
    78,615 USD0SEC
    2,604 shares@ US$30.19Common StockSEC:0001203311-13-000008:7
  • ◇
    Chief Medical OfficerExecutivesSeagen Inc.
    40,800 USD0SEC
    3,679 shares@ US$11.09Common StockSEC:0001203311-13-000006:0
  • ▼
    Chief Medical OfficerExecutivesSeagen Inc.
    103,049 USD0SEC
    3,679 shares@ US$28.01Common StockSEC:0001203311-13-000006:1
  • ◇
    Chief Medical OfficerExecutivesSeagen Inc.
    393,606 USD0SEC
    35,492 shares@ US$11.09Common StockSEC:0001203311-13-000006:2
  • ▼
    Chief Medical OfficerExecutivesSeagen Inc.
    993,776 USD0SEC
    35,492 shares@ US$28.00Common StockSEC:0001203311-13-000006:3
  • ◇
    Chief Medical OfficerExecutivesSeagen Inc.
    393,617 USD0SEC
    35,493 shares@ US$11.09Common StockSEC:0001203311-13-000006:4
  • ▼
    Chief Medical OfficerExecutivesSeagen Inc.
    993,804 USD0SEC
    35,493 shares@ US$28.00Common StockSEC:0001203311-13-000006:5
  • ◇
    Chief Medical OfficerExecutivesSeagen Inc.
    409,099 USD0SEC
    33,643 shares@ US$12.16Common StockSEC:0001203311-13-000006:6
  • ▼
    Chief Medical OfficerExecutivesSeagen Inc.
    942,340 USD0SEC
    33,643 shares@ US$28.01Common StockSEC:0001203311-13-000006:7
  • ◇
    Chief Medical OfficerExecutivesSeagen Inc.
    151,260 USD0SEC
    12,605 shares@ US$12.00Common StockSEC:0001203311-13-000006:8
  • ▼
    Chief Medical OfficerExecutivesSeagen Inc.
    353,066 USD0SEC
    12,605 shares@ US$28.01Common StockSEC:0001203311-13-000006:9
  • ◇
    Chief Medical OfficerExecutivesSeagen Inc.
    64,422 USD0SEC
    4,167 shares@ US$15.46Common StockSEC:0001203311-13-000006:10
  • ▼
    Chief Medical OfficerExecutivesSeagen Inc.
    116,718 USD0SEC
    4,167 shares@ US$28.01Common StockSEC:0001203311-13-000006:11
  • ◇
    Chief Medical OfficerExecutivesSeagen Inc.
    364,800 USD0SEC
    30,000 shares@ US$12.16Common StockSEC:0001203311-12-000118:0
  • ▼
    Chief Medical OfficerExecutivesSeagen Inc.
    773,100 USD0SEC
    30,000 shares@ US$25.77Common StockSEC:0001203311-12-000118:1
  • ◇
    Chief Medical OfficerExecutivesSeagen Inc.
    308,700 USD0SEC
    30,000 shares@ US$10.29Common StockSEC:0001203311-12-000118:2
  • ▼
    Chief Medical OfficerExecutivesSeagen Inc.
    773,100 USD0SEC
    30,000 shares@ US$25.77Common StockSEC:0001203311-12-000118:3

25 of 103 declarations